A Health Economic Analysis of the Long-Term Outcomes and Costs Associated with Using Canagliflozin Versus Sitagliptin As an Add-On to Metformin (MET) in Mexico
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.2057
https://www.valueinhealthjournal.com/article/S1098-3015(13)03969-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1882
First Page :
A689
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03969-7&doi=10.1016/j.jval.2013.08.2057